Cargando…
Complementary treatment of allergic rhinoconjunctivitis: the role of the nutraceutical Lertal®
Nutraceuticals represent interesting therapeutic options in clinical practice. In this regard, a new compound has been designed: Lertal(®). It contains quercetin, perilla extract, and vitamin D(3). These agents exert anti-allergic and anti-inflammatory activities. This article reports and discusses...
Autores principales: | Marseglia, Gianluigi, Licari, Amelia, Ciprandi, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569599/ https://www.ncbi.nlm.nih.gov/pubmed/32191661 http://dx.doi.org/10.23750/abm.v91i1.9275 |
Ejemplares similares
-
Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis
por: Tosca, Maria Angela, et al.
Publicado: (2020) -
Small airways in children with allergic rhinoconjunctivitis: the potential role of a multicomponent nutraceutical
por: Leonardi, Salvatore, et al.
Publicado: (2020) -
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II
por: Marseglia, Gianluigi, et al.
Publicado: (2019) -
Allergic rhinoconjunctivitis: pathophysiological mechanism and new therapeutic approach
por: Ciprandi, Giorgio, et al.
Publicado: (2020) -
Respiratory infections in allergic children: the preventive role of a multicomponent nutraceutical
por: Zicari, Anna Maria, et al.
Publicado: (2020)